about
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EP...
Read More
20.89
0.11
(0.53%)
725.5K
XNAS Volume
XNAS 20 Jan, 2026 4:00 PM (EST)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
DBV Tech (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..